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ABSTRACT
Motor activity in healthy young humans displays intrinsic fluctuations that are scale-invariant over
a wide range of time scales (from minutes to hours). Human postmortem and animal lesion
studies showed that the intact function of the suprachiasmatic nucleus (SCN) is required to
maintain such scale-invariant patterns. We therefore hypothesized that scale invariance is
degraded in patients treated for suprasellar tumors that compress the SCN. To test the hypothesis,
we investigated 68 patients with nonfunctioning pituitary macroadenoma and 22 patients with
craniopharyngioma, as well as 72 age-matched healthy controls (age range 21.0–70.6 years).
Spontaneous wrist locomotor activity was measured for 7 days with actigraphy, and detrended
fluctuation analysis was applied to assess correlations over a range of time scales from minutes to
24 h. For all the subjects, complex scale-invariant correlations were only present for time scales
smaller than 1.5 h, and became more random at time scales 1.5–10 h. Patients with suprasellar
tumors showed a larger decrease in correlations at 1.5–10 h as compared to healthy controls.
Within healthy subject, gender and age >33 year were associated with attenuated scale invar-
iance. Conversely, activity patterns at time scales between 10 and 24 h were significantly more
regular than all other time scales, and this was mostly associated with age.
In conclusion, scale invariance is degraded in healthy subjects at the ages of >33 year as
characterized by attenuation of correlations at time scales 1.5–10 h. In addition, scale invariance
was more degraded in patients with suprasellar tumors as compared to healthy subjects.
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Introduction
Although our daily movements might seem com-
pletely voluntary, motor activity in both humans
and rats is enslaved by an underlying intrinsic
pattern that is similar across different time scales
ranging from minutes to hours, independent of
extrinsic scheduled events, environmental influ-
ences and activity levels (Hu et al., 2004; Hu
et al., 2007; Hu et al., 2012). This phenomenon
of self-similarity or fractality, in which temporal
fluctuation patterns are repeated across different
time scales, is known as scale invariance.
Researchers have sought intensively for anato-
mical structures responsible for this regulation.
Lesions of the suprachiasmatic nucleus (SCN) in
rodents abolish scale-invariant correlations of
locomotor activity at scales larger than 4 h (Hu
et al., 2007). This means that the hypothalamic
clock orchestrating circadian (~24 h) rhythms in
physiology and behavior (Welsh et al., 2010) also
directs fluctuation patterns at time scales smaller
than 24 h, either as a self-contained multi-oscilla-
tor system or by interacting with a network of
other activity control nodes. Furthermore, com-
pared to young people, older individuals show
reductions in scale-invariant correlations for scales
larger than 1.5 h, with an additional decrease in
those with Alzheimer’s disease (Hu et al., 2009).
CONTACT Johanna H. Meijer J.H.Meijer@lumc.nl Department of Molecular Cell Biology, Laboratory for Neurophysiology, Leiden University Medical
Center, PO Box 9600, Leiden 2300RC, The Netherlands
N. R. Biermasz and J. H. Meijerauthors contributed equally.
Supplemental data for this article can be accessed on the publisher’s website.
CHRONOBIOLOGY INTERNATIONAL
2018, VOL. 35, NO. 3, 368–377
https://doi.org/10.1080/07420528.2017.1407779
© 2017 The Author(s). Published by Taylor & Francis Group, LLC
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/),
which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
Both aging and Alzheimer’s disease are associated
with disturbances of sleep and daily activity, which
are thought to be caused by associated neuroana-
tomical changes in the SCN (Swaab et al., 1985;
Zhou et al., 1995; Liu et al., 2000; Wu et al., 2006;
Harper et al., 2008). Therefore, these results
further support the role of the SCN in scale invar-
iance also in humans (Pittman-Polletta et al.,
2013) such that scale invariance of motor activity
may potentially be used as a noninvasive marker of
SCN function in humans (Hu et al., 2013).
However, previous observations of alterations in
scale invariance were based on a relatively small
sample size, with analyses limited to data during
daytime, time scales smaller than 8 h, and subjects
under extreme conditions such as Alzheimer’s dis-
ease and very old age (e.g., no or few healthy
subjects between 30–50 years old). To better
understand the effects of aging and SCN dysfunc-
tion on scale invariance, we assessed scale invar-
iance of motor activity over a broader range of
time scales from minutes up to 24 h, in much
larger groups of healthy individuals (n = 72) and
patients with a history of compression of the SCN
(n = 90) – i.e., patients treated for large benign
suprasellar tumors such as nonfunctioning pitui-
tary macroadenomas (NFMA) and craniopharyn-
giomas. These tumors compress surrounding
tissue and present with pituitary insufficiency,
visual field defects and headache (Jaffe, 2006;
Stamm et al., 2011). Following transsphenoidal
adenomectomy, patients chronically suffer from
daytime somnolence, reduced sleep efficiency,
fragmented sleep-wake patterns, and alterations
of diurnal melatonin and temperature rhythmicity
(Ullrich et al., 2005; Biermasz et al., 2011; Joustra
et al., 2014a; Joustra et al., 2014b; Pickering et al.,
2014; Pickering et al., 2017). These symptoms are
strongly associated with suprasellar tumor exten-
sion (irrespective of hypopituitarism), implying
damage to suprasellar structures, e.g., the optic
tract or the ventral hypothalamus (most notably
the adjacent SCN). The goal was to investigate the
robustness of the scale invariance measure to
detect healthy and possibly altered SCN function-
ing. We hypothesized that scale invariance is
degraded in patients treated for suprasellar tumors
and in a physiological condition of attenuated
day–night rhythmicity, i.e., in older individuals.
Subjects and methods
Design
For this study, we analyzed wrist motor activity
data collected from patients treated for NFMA
or craniopharyngioma, and age-matched
healthy individuals during normal daily activity
at home. Using these data, detrended fluctua-
tion analysis was performed to assess scale
invariance. The Medical Ethics Committees of
the Leiden University Medical Center and
Copenhagen University Hospital approved the
study protocols (P12.237 and H3.2011.057,
respectively), and all subjects gave written
informed consent.
Subjects
We examined wrist motor activity recordings of
72 healthy individuals (57 Dutch and 15
Danish; 34 women and 38 men; 20–70 years
old) and 90 patients treated for NFMA or cra-
niopharyngioma (75 Dutch and 15 Danish; 40
women and 35 men; 18–70 years old) that were
collected from two previous studies (Joustra
et al., 2014a; Joustra et al., 2014b; Pickering
et al., 2014). Inclusion criteria for NFMA and
craniopharyngioma were long-term remission
(absence of, or stable residual adenoma) after
transsphenoidal surgery for these adenomas at
least one year ago, adequate and stable hor-
mone replacement therapy for hypopituitarism
(see below), and age between 18 and 70 years.
Surgery was followed by radiotherapy in
selected cases. We excluded patients with diag-
nosed sleep disorders (e.g., obstructive sleep
apnea or periodic legs movement) or use of
sleep-promoting- or psychotropic medication.
The NFMA were staged according to the classi-
fication by Hardy–Wilson (Hardy, 1979). Visual
field defects were diagnosed by standard
Goldmann perimetry. An endocrinologist peri-
odically evaluated the patients. Pituitary insuf-
ficiency (see Supplementary data for
definitions) was treated with hydrocortisone,
levothyroxine, recombinant human growth hor-
mone (unless contraindicated or not preferred),
testosterone in men and estrogen in combina-
tion with progestogens in premenopausal
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women. Dosages were monitored and adjusted
as required. Stable replacement was assumed
when medication was not adjusted for 4 months,
complaints were absent, and basal hormone
levels showed adequate replacement.
The age-matched healthy participants fulfilled
the same inclusion and exclusion criteria, except
for pituitary pathology.
All Dutch subjects were evaluated at the
Leiden University Medical Center in the
Netherlands, mostly during the spring (68.6%)
and winter (21.2%) of 2013. All Danish subjects
were evaluated at the Rigshospitalet in
Copenhagen Denmark, mostly in the fall
(40.0%), winter (46.7%) and spring (13.3%) of
2011–2012.
Actigraphy
Motor activity levels were assessed continuously
for 7 consecutive days and nights using an
Actiwatch AW7 (CamNtech, Cambridge, UK)
in Dutch subjects and an Actiwatch Spectrum
(Philips Respironics, Murrysville, PA, USA) in
Danish subjects, worn on the nondominant
wrist. Subjects maintained their habitual sleep-
wake schedules. The accelerometer records the
highest amplitude of wrist movement per sec-
ond in counts (one count representing 0.04 g),
and sums these counts in epochs of 1 minute.
Actigraphic measurements from Denmark were
initially recorded in epochs of 30 seconds for
14 days. For the current analysis, only the first
7 days of the Danish data were used, and 1-
minute epochs were formed by summation of
two subsequent 30-second epochs.
Using nonparametric calculations, we calcu-
lated the interdaily stability, which quantifies
similarity of rest-activity rhythms between days,
and the intradaily variability, which indicates
fragmentation of the day–night rhythm within
individual days (Van Someren et al., 1999).
Furthermore, averaging the activity patterns of
the 7 registration days created an average 24-h
activity pattern. From this 24-h pattern, the
average movement per epoch of 1 minute was
calculated for the hours spent awake, as deter-
mined by the actiwatch sleep analysis sleep scor-
ing algorithm. To avoid any influence of
differences in actigraphy sensitivity, analyses
that include activity levels were only performed
in Dutch subjects.
We refer to our previous work for the results of
standard actigraphic variables as well as subjective
sleep quality, fatigue and daytime sleepiness in
these patients (Joustra et al., 2014a; Joustra et al.,
2014b; Pickering et al., 2014).
Assessment of scale invariance using detrended
fluctuation analysis
Detrended fluctuation analysis was used to deter-
mine correlations of activity fluctuations at time
scales from minutes to 24 h. It derives the amplitude
of activity fluctuations, F(n), at different time scales
n. To eliminate the potential effects of trends in the
recordings, the second order polynomial function
was used to detrend the data in the analysis. Scale
invariance is characterized by a power-law form of
the fluctuation function, F(n)≈nα, with the scaling
exponent α indicating correlations in fluctuations:
α = 0.5 represents no correlation in activity fluctua-
tions, indicating complete randomness (or white
noise) which is thought to reduce the system’s ability
to orchestrate its subsystems appropriately in
response to external stimuli; α > 0.5 indicates posi-
tive correlations in activity fluctuations (i.e., large
values have more probability of being followed by
large values and vice versa); and α = 1.5 indicates too
much regularity (or Brownian/red noise), which
restricts the functional responsiveness of the system,
making it vulnerable to catastrophic events (Huikuri
et al., 2000; Perkiomaki et al., 2001). Healthy physio-
logical systems show a delicate balance between these
two at α ~ 1.0 (pink noise) (Goldberger et al., 2002)
indicating strong positive correlations with the high-
est complexity. Detailed description of the method is
described in Gu et al. (Gu et al., 2015). The scaling
exponent α was calculated using regression to obtain
the best power-law fit of data: F(n)≈nα.
Statistical analysis
Statistical significance of mean differences between
healthy participants and either of the patient
groups were assessed using the two-tailed indepen-
dent Student’s t-test or, in case the assumption of
normality was not met (Shapiro–Wilk test), the
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Mann–Whitney U test. Categorical data were com-
pared using the Chi-square test or, when the
expected cell count was <5, the Fisher’s exact
test. Paired t-test was used to calculate statistical
significance of differences between α1, α2 and α3.
Three types of generalized linear regression mod-
els were used to assess determinants of outcome
variables. To test the hypothesis that aging and
disease are associated with degraded scale invar-
iance, model 1 assessed the influence of age, gen-
der, mean activity levels and disease (NFMA and
craniopharyngioma combined) and their interac-
tions on α1 (scaling exponent at time scales of
0.25–1.5 h), α2 (1.5–10 h) or α3 (10–24 h). To
test the hypothesis that degraded scale invariance
is associated with objective and subjective para-
meters of altered circadian rhythmicity, model 2
assessed the influences of both α2 and Δα1–α2 (as
well as age, gender and activity levels) on acti-
graphic sleep duration, sleep efficiency, intradaily
variability or interdaily stability (Joustra et al.,
2014a), and subjective sleep quality (Pittsburgh
sleep quality index (Buysse et al., 1989)), fatigue
(multidimensional fatigue inventory (Smets et al.,
1995)), or daytime sleepiness (Epworth sleepiness
scale (Johns, 1991)). Lastly, to test the hypothesis
that suprasellar extension causing visual field
defects is associated with degraded scale invar-
iance, model 3 assessed the effect of hypopituitar-
ism, previous radiotherapy and preoperative visual
field defects (as well as age, gender and activity
levels) and their interactions on each α. In each
model, the least-significant co-variates were
removed sequentially, until all co-variates signifi-
cantly contributed to the model. Then, Akaike’s
information criterion, which measures the trade-
off between goodness of fit and complexity of the
model, was used to determine whether the model
could be further simplified. The regression coeffi-
cient B was used to express effect size. Differences
were considered statistically significant at p < 0.05.
Results
Clinical characteristics
The 72 healthy subjects had a median age of
55.5 years (range 21.0–70.6 years) and 47.2%
were women.
Patients with NFMA (n = 68, 48.5% women) in
long-term remission after transsphenoidal surgery
for suprasellar tumor extension had a median age
of 59.4 years (range 26.0–70.1 years) (Table 1).
Before surgery, suprasellar tumor extension was
observed in 94% of cases, and visual field defects
in 77.9%. At the time of the actigraphic evaluation,
hypopituitarism was present in 82.4%, and all
patients received proper and stable replacement
therapy except for optional growth hormone
replacement, which was left untreated in 15 of 49
growth hormone deficient patients. NFMA
patients displayed more intradaily variability
(p = 0.005) and less interdaily stability
(p = 0.026) than the healthy group.
Table 1. Clinical characteristics.
Healthy participants
(n = 72)
NFMA patients
(n = 68)
Craniopharyngioma patients
(n = 22)
Age (years) 55.5 (44.0–64.0) 59.4 (51.5–63.5) 51.7 (33.3–62.1)
Women 34 (47.2%) 33 (48.5%) 7 (31.8%)
BMI (kg/m2) 26.2 (23.4–29.8) 27.2 (25.3–29.5) 28.9 (25.8–32.6)*
Adjuvant radiotherapy 20 (29.4%) 7 (31.8%)
Preoperative VFD 53 (77.9%) 14 (63.6%)
Suprasellar extensiona 64 (94%) 22 (100%)
Hypopituitarism 56 (82.4%) 22 (100%)
ACTH deficiency 31 (45.6%) 18 (81.8%)
TSH deficiency 41 (60.3%) 22 (100%)
GH deficiency 49 (72.1%) 20 (90.9%)
LH/FSH deficiency 38 (55.9%) 19 (86.4%)
Vasopressin deficiency 7 (10.3%) 14 (63.6%)
Intradaily variability 0.35 (0.30–0.43) 0.40 (0.34–0.50)** 0.38 (0.34–0.51)
Interdaily stability 0.84 (0.76–0.89) 0.80 (0.68–0.84)* 0.78 (0.67–0.87)
Activity during wake (counts)b 254 (211–323) 243 (194–280) 236 (215–295)
Data represent median (interquartile range) or number (percentage). aHardy–Wilson classification (Hardy, 1979) minimal II-B. bAverage activity per
minute during hours spend awake in counts, each count representing 0.04 g of wrist acceleration per second. NFMA: nonfunctioning pituitary
macroadenoma. VFD: visual field defects. *p < 0.05 or **p < 0.01 compared to healthy subjects.
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Furthermore, 22 patients in long-term remis-
sion after surgery for craniopharyngioma (31.8%
women), with a median age of 51.7 years (range
18.2–70.2 years) were studied. The majority of the
patients had visual field defects preoperatively
(63.6%). At the time of the actigraphic evaluation,
all had hypopituitarism, vasopressin deficiency
was present in 63.6%, and all received proper and
stable replacement therapy. Differences between
craniopharyngioma patients (CP) and the healthy
group in intradaily variability and interdaily stabi-
lity did not reach statistical significance (p = 0.109
and p = 0.058, respectively). CP displayed a higher
body mass index than healthy participants
(p = 0.027). Dutch and Danish participants, both
patients and healthy subjects, did not differ sig-
nificantly in gender or age.
Scale invariance of activity fluctuations
Figure 1A shows the averaged detrended fluctuation
function F(n) across time scales 0.25–24 h for each
group. As can be observed, scaling behavior differed
in three regions: n1 ≈ 0.25–1.5 h, n2 ≈ 1.5–10 h and
n3 ≈ 10–24 h. These breakpoints can be seen more
clearly in Figure 1B, representing the change in F(n)
per n [F(n)/n] with slope α’ (which is α–1). Slopes α1,
α2 and α3 were calculated for the three regions n1, n2
and n3, respectively (Figure 2). Complex activity
fluctuations with strong correlations (α1 ≈ 1) were
observed across the lower time scales (α1 at
n1 < 1.5 h) in healthy subjects (α1 [mean±SD]:
0.98 ± 0.07), NFMA (α1: 0.99 ± 0.07) and cranio-
pharyngioma (α1: 0.99 ± 0.06). For scales from 1.5 to
10 h (n2), all groups showed a reduction in scale-
invariant correlations, as the scaling exponent α2
decreased significantly (all p < 0.001) in healthy
subjects (α2: 0.89 ± 0.09), NFMA (α2: 0.85 ± 0.09)
and craniopharyngioma patients (α2: 0.86 ± 0.09).
For the time scales from 10 to 24 h (n3), a dramatic
inversion of scale-invariant correlations (all
p < 0.001) toward red noise (also known as
Brownian noise) was observed in healthy subjects
(α3: 1.27 ± 0.21), NFMA (α3: 1.26 ± 0.17) and cra-
niopharyngioma (α3: 1.20 ± 0.19).
There were no significant effects of activity
levels, age, gender or disease on α1 (model 1).
For the second timescale region n2, α2 was lower
(more random activity fluctuations) in patients as
compared to controls (p = 0.014) (Table 2).
Disease and gender showed two interaction effects
on α2 (p = 0.010): women showed lower α2 than
men only within healthy subjects, and the decrease
in α2 in patients was significantly stronger in men
(Figure 3). Within the healthy control group, one-
way ANOVA showed a difference in α2 between
the age groups (p = 0.003), i.e., α2 was around 1.0
(indicating the most complex fluctuations) in the
youngest subgroup (18–33 years) and was signifi-
cantly smaller in the other age subgroups (Tukey
post hoc). The age groups were based on those
used in the study of Hu et al. (Hu et al., 2009), and
no effects of age groups were observed in patients
(p = 0.595). We also observed a small interaction
effect of age and activity levels on α2 (p = 0.021), as
the positive association between activity and α2
was stronger in older subjects. The difference
between α1 and α2 (Δ = α1–α2), as a direct test of
a decrease in scale invariance, was solely influ-
enced by disease (p = 0.006). For the largest
time-scale region n3, a larger α3 correlated with
age (p = 0.003, +0.193 per decade), and with
higher activity level (p = 0.001, +0.472 for every
increase of 100 activity counts per minute). In
addition, the association between α3 and activity
levels was influenced by age, i.e., it was positive in
subjects <66 years old and negative at > 66 years
old (Supplemental Figure S2). Although statisti-
cally significant, this interaction effect was consid-
erably smaller than the individual effects of age
and activity (p = 0.004, B = −0.069).
Furthermore, lower α2 was associated with more
fatigue (p = 0.017) and larger Δ = α1–α2 with
better intradaily stability (p = 0.032) (model 2).
Neither α2 nor Δ = α1–α2 were associated with
subjective sleep quality, daytime sleepiness, sleep
duration, sleep efficiency or intradaily variability.
Lastly, within patients, we observed a significant
interaction between the effects of activity levels
and radiotherapy on α2 (model 3), as the associa-
tion between higher activity levels and higher α2
was only present in patients without radiotherapy
(p = 0.014, B = −0.067, Supplemental Figure S1).
No effects of patient characteristics (model 3) on
α1, α1–α2 or α3 were observed.
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Discussion
The results of this study demonstrate that scale
invariance of activity patterns in humans degrades
already during midlife. Larger attenuations of scale
invariance were observed in patients treated for
suprasellar tumors, as well as in women, with
older age, and with lower activity levels.
Within the entire time scale window from min-
utes to 24 h, complex scale-invariant correlations
were only observed for time scales smaller than
1.5 h, and became more random at time scales
1.5–10 h. Hu et al. observed a remarkably similar
breakpoint at 1.5 h in older individuals
(80.8 ± 8.6 years old) and in very old patients
with Alzheimer’s disease (Hu et al., 2009). The
Figure 1. Average detrended fluctuation functions F(n) from locomotor activity data of 72 healthy controls, 68 NFMA patients and 22
craniopharyngioma patients. Data are shown on log-log plots and curves are vertically shifted in [A] for better visualization of differences
between groups (vertical offset does not alter the slope). The scaling behavior can be separated in three time scale regions based on two
breakpoints at ~1.5 h and ~10 h. The break points can be seen more clearly when F(n) is divided by time scale n in [B], indicating the
change in F(n) per time unit n. The straight lines represent perfect scale-invariance α = 1.00 [A] or α’ = 0.00 [B].
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attenuation of scale-invariant correlations for
scales 1.5–10 h in those groups were larger than
we observed in our patients and healthy subjects,
which may be explained by more severe SCN
dysfunction in old age and Alzheimer’s disease
(Swaab et al., 1985; Zhou et al., 1995; Liu et al.,
2000; Wu et al., 2006; Harper et al., 2008). The
study reported no breakpoint in scale invariance in
healthy young subjects (n = 13, 25.5 ± 6.1 years)
(Hu et al., 2009), which was confirmed in our
study as Figure 3 shows an α2 around 1.0 in the
corresponding healthy young age group (18–
33 years). In addition, our results show that α2
decreases quickly after the age of 33 year, espe-
cially in women.
Our observation of a second breakpoint at
~10 h has not been reported previously, either
because large time scales were not assessed (Hu
et al., 2009) or because the exponent α was only
calculated for the entire observation window (Hu
et al., 2007), although the two breakpoints were
visible in their display of data (Hu et al., 2007).
As we observed no effect of disease on activity
correlations at time scales larger than 10 h, the
increased regularity in this time scale region may
depend less on SCN functioning and more on
environmental and behavioral cues, (e.g., our
environmental light-dark cycle, sleep-wake
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Figure 2. Scaling exponent α in 72 healthy controls, 68 NFMA patients and 22 craniopharyngioma patients (CP), obtained from
detrended fluctuation analysis, separated in three time scale (n) regions of the 24-h analysis period. The dotted lines represent too
much randomness or white noise at α = 0.5, too much regularity or red noise at α = 1.5, and the delicate balance between the two
in healthy systems known as complex scale invariance or pink noise at α = 1.0. Bars represent mean ± SD.
Table 2. Associations with the scaling exponent α.
B 95% CI p-Value
α2 at time scales 1.5–10 h
Disease −0.074 −0.114–−0.034 0.014
Disease*gender −0.068a −0.113–−0.024 0.010
Age*activity levels 0.003b,c 0.001–0.006 0.021
Only in patients
Radiotherapy*activity levels 0.041b 0.012–0.070 0.019
Δ = α1–α2
Disease 0.058 0.016–0.099 0.006
α3 at time scales 10–24 h
Age 0.193c 0.066–0.320 0.003
Activity levels 0.472b 0.197–0.747 0.001
Age*activity levels −0.069b,c −0.021–−0.116 0.004
Data represented factors included in the linear regression model
that were best able to predict scaling exponent α at different time
scales. aI.e., the disease effect is stronger in men than women. bB
for higher activity level: increase of 100 counts per 1-minute
epoch. cB for age: increase of 10 years. *: interaction. Disease:
NFMA or craniopharyngioma.
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schedule and daily work schedule). Therefore,
although complexity (alpha close to one) is a
biomarker of healthy physiology, this might not
be the case, or the intrinsic patterns can be
masked, at larger time scales where imposed
environmental rhythms play an important role.
Aging was associated with further increased reg-
ularity at this larger time scale, which might
imply reduced integration and orchestration of
the SCN with other oscillators of motor activity
control, or might reflect more dominating envir-
onmental or behavioral influences.
We observed an additional decrease of α2 in
patients treated for tumors with suprasellar exten-
sion. Furthermore, Figure 3 shows that complex
scale-invariant correlations during time scales 1.5–
10 h are already decreased in young patients as
compared to healthy controls. A history of supra-
sellar tumor extension is therefore an additional
risk factor for a decrease in the scale-invariant
correlations at time scales that have previously
been shown to be affected by the SCN. Within
patients, we observed an association between
higher activity levels and larger α2 (close to 1)
only in those that without a history of radiother-
apy, but there was no main effect of radiotherapy
on α2. The explanation for this phenomenon
remains unclear, but due to the observational
nature of the data we cannot exclude confounding
factors, e.g., by indications for radiotherapy.
Although Gu et al. observed strong effects of
regular exercise on scale invariance in mice (Gu
et al., 2015), we observed marginal associations of
α2 with differences in activity level. As our study is
observational, we cannot draw causal conclusions,
and variations in activity might have been too
small to show an effect. Future intervention stu-
dies in cohorts of young versus middle-aged
healthy individuals should be performed to deter-
mine whether significantly improving activity
levels results in a change in scale-invariant
correlations.
The observed attenuation of scale-invariant
correlations at time scales between 1.5–10 h in
our healthy subjects indicated that even in
healthy middle-aged individuals, the physiologi-
cal balance between regularity and randomness is
suboptimal. The complex physiological fluctua-
tions that resemble pink noise are thought to
reflect system plasticity and adaptability in
response to unpredictable stimuli and stressors
because the alterations have been associated with
pathologic conditions. For instance, altered cor-
relations in heart rate fluctuations are observed
in patients with heart failure (Huikuri et al.,
2000; Makikallio et al., 2001a; Makikallio et al.,
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2001b) and atrial fibrillation (Vikman et al.,
1999), and more random gait is observed in
Huntington’s disease (Hausdorff et al., 1997).
The clinical significance of suboptimal scale
invariance in activity patterns has not been
established yet, although lower activity correla-
tion at 1.5–10 h or its difference from the corre-
lation at smaller time scales has been associated
with increased age, with Alzheimer’s disease and
with neurotransmitter content in the SCN in
postmortem studies (Hu et al., 2009; Hu et al.,
2013). In the current study, decreased α2 was
associated with complaints of fatigue. Future stu-
dies are warranted to investigate the mechanism
underlying the association.
Strengths of the current study were the large
groups included in the study, allowing investiga-
tion of various associations. Limitations include
the sensitivity of the actigraph, whose signal-to-
noise ratio becomes more unfavorable during per-
iods of low upper extremity movements, especially
during the sleep/nap episodes. We did not con-
sider the potential effects of light intensity on
activity patterns. The sample size in our younger
subgroups was small, requiring further studies to
determine the exact time course of deterioration of
α2 across age. Also, the extent of SCN dysfunction-
ing in our patients was not known as no direct
measure of SCN functioning exists. However,
patients had other indirect signs of SCN dysfunc-
tioning, i.e., altered objective and subjective sleep-
wake cycle (Biermasz et al., 2011; Joustra et al.,
2014a; Pickering et al., 2014). In a subset of
patients, rhythmicity of melatonin, temperature
and sleep quality were measured and found to be
disturbed, albeit in variable patterns (Joustra et al.,
2014b).
In conclusion, the results of this study have
demonstrated that healthy middle-aged subjects
show robust scale invariance of activity patterns
at time scales of up to 1.5 h, which attenuated at
larger scales leading to more random activity fluc-
tuations at time scales from 1.5 to 10 h and more
regular activity patterns at time scales from 10 to
24 h. Activity patterns at time scales between 1.5
and 10 h were more affected in patients with
suprasellar tumors, in line with previous reports
associating these time scales with SCN function.
We also observed effects of gender on activity
patterns at time scales 1.5–10 h, as well as a
rapid decline in activity correlations with age
(starting as early as approximately 33 years old).
Scale invariance is therefore already starting to
become fragile in healthy middle-aged subjects.
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